You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南京高科(600064.SH):股權投資業務參投項目仁度生物科創板IPO過會
格隆匯 11-15 15:39

格隆匯11月15日丨南京高科(600064.SH)公佈,根據2021年11月12日上交所科創板上市委員會2021年第85次審議會議結果公吿,公司股權投資業務參股投資項目上海仁度生物科技股份有限公司(簡稱“仁度生物”)提交的首次公開發行股票並在科創板上市的申請獲得審議通過,後續還將根據中國證監會及上交所的相關規定及要求開展相關工作,報經證監會註冊同意後在科創板發行上市。

仁度生物成立於2007年,是一家專注於RNA分子診斷技術與產品的高新技術企業。2019年5月,公司發起設立的南京高科新浚成長一期股權投資合夥企業(有限合夥)(公司出資比例為69.65%,簡稱“高科新浚一期基金”)投資了仁度生物。截至目前,高科新浚一期基金持有仁度生物95.5413萬股,佔其發行前總股本的3.1847%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account